Compare TXG & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | NVST |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | 2019 | 2019 |
| Metric | TXG | NVST |
|---|---|---|
| Price | $34.76 | $25.81 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $20.25 | ★ $26.46 |
| AVG Volume (30 Days) | ★ 3.1M | 2.8M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 76.97 | ★ 104.31 |
| EPS | N/A | ★ 0.23 |
| Revenue | $245,893,000.00 | ★ $2,566,500,000.00 |
| Revenue This Year | N/A | $6.67 |
| Revenue Next Year | $7.33 | $3.55 |
| P/E Ratio | ★ N/A | $108.09 |
| Revenue Growth | ★ 68.06 | N/A |
| 52 Week Low | $10.51 | $18.32 |
| 52 Week High | $35.65 | $30.42 |
| Indicator | TXG | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 70.12 | 64.69 |
| Support Level | $16.11 | $24.21 |
| Resistance Level | $35.65 | $26.63 |
| Average True Range (ATR) | 2.41 | 0.79 |
| MACD | 0.21 | 0.32 |
| Stochastic Oscillator | 88.10 | 88.82 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.